Abstract
Adriamycin inhibits the succinoxidase system and the NADH-oxidase system. Both of the intact mitocondrial enzymes and the pentane-extracted preparations are inhibited. The inhibition can be prevented by a molar ratio of coenzyme to adriamycin of 3:1 for coenzyme Q10 (ubiquinone), 5:1 for coenzyme Q7, and 5:1 for coenzyme Q4. Prevention of inhibition was observed in the decreasing order of coenzyme Q10 greater than coenzyme Q7 greater than H6 coenzyme Q4 greater than coenzyme Q4. Adriamycinone was three times more inhibitory than adriamycin, which is compatible with a less polar fragment necessary to inhibit the lipoidal coenzyme Q10. Daunomycinone was not inhibitory at a concentration at which adriamycinone is effective, indicating that the hydroxyl group of the latter could be binding at the receptor, since it should not influence electron transfer or rings B and C.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bachmann E., Weber E., Zbinden G. Effects of seven anthracycline antibiotics on electrocardiogram and mitochondrial function of rat hearts. Agents Actions. 1975 Oct;5(4):383–393. doi: 10.1007/BF02205248. [DOI] [PubMed] [Google Scholar]
- Folkers K. The potential of coenzyme Q 10 (NSC-140865) in cancer treatment. Cancer Chemother Rep 2. 1974 Dec;4(4):19–22. [PubMed] [Google Scholar]
- Gosalvez M., Blanco M., Hunter J., Miko M., Chance B. Effects of anticancer agents on the respiration of isolated mitochondria and tumor cells. Eur J Cancer. 1974 Sep;10(9):567–574. doi: 10.1016/0014-2964(74)90044-9. [DOI] [PubMed] [Google Scholar]
- Iwamoto Y., Hansen I. L., Porter T. H., Folkers K. Inhibition of coenzyme Q10-enzymes, succinoxidase and NADH-oxidase, by adriamycin and other quinones having antitumor activity. Biochem Biophys Res Commun. 1974 Jun 4;58(3):633–638. doi: 10.1016/s0006-291x(74)80465-1. [DOI] [PubMed] [Google Scholar]
- Iwamoto Y., Nakamura R., Folkers K., Morrison R. F. Study of periodontal disease and coenzyme Q. Res Commun Chem Pathol Pharmacol. 1975 Jun;11(2):265–271. [PubMed] [Google Scholar]
- Kishi H., Kishi T., Folkers K. Bioenergetics in clinical medicine. III. Inhibition of coenzyme Q10-enzymes by clinically used anti-hypertensive drugs. Res Commun Chem Pathol Pharmacol. 1975 Nov;12(3):533–540. [PubMed] [Google Scholar]
- Kishi T., Folkers K. Letter: Prevention by coenzyme Q10 (NSC-140865) of the inhibition by adriamycin (NSC-123127) of coenzyme Q10 enzymes. Cancer Treat Rep. 1976 Mar;60(3):223–4?U9ENG. [PubMed] [Google Scholar]
- LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
- Lenaz G., Pasquali P., Bertoli E., Parenti-Castelli G. The inhibition of NADH oxidase by the lower homologs of coenzyme Q. Arch Biochem Biophys. 1975 Jul;169(1):217–226. doi: 10.1016/0003-9861(75)90335-5. [DOI] [PubMed] [Google Scholar]
- Littarru G. P., Ho L., Folkers K. Deficiency of coenzyme Q 10 in human heart disease. II. Int J Vitam Nutr Res. 1972;42(3):413–434. [PubMed] [Google Scholar]
- Shichiri M., Shigeta Y., Abe H., Izumi K., Redalieu E., Folkers K. Apparent low levels of ubiquinone in rat and human neoplastic tissues. Int Z Vitaminforsch. 1968;38(5):472–481. [PubMed] [Google Scholar]
- Skelton F. S., Porter T. H., Littarru G. P., Folkers K. Antimetabolites of coenzyme Q. XV. Inhibition of mitochondrial reductase systems by naphthoquinone and quinolinequinone analogs. Int J Vitam Nutr Res. 1973;43(2):150–164. [PubMed] [Google Scholar]
- Wikholm R. J., Iwamoto Y., Bogentoft C. B., Porter T. H., Folkers K. Synthesis and bioassays of a new dimethoxyalkylmercapto-1,4-benzoquinones. J Med Chem. 1974 Aug;17(8):893–896. doi: 10.1021/jm00254a023. [DOI] [PubMed] [Google Scholar]